Natera Inc (NTRA)

$44.97 0.23 (0.51%)

16:00 EDT NTRA Stock Quote Delayed 30 Minutes

Eddie Pan

Why Is Natera (NTRA) Stock Up Today?

By Eddie Pan, InvestorPlace Financial News Writer Mar 10, 2022

NTRA stock is flying higher after the company addressed Hindenburg's short report. Wall Street analysts are on Natera's side as well.

Why Is Natera (NTRA) Stock Down Today?

7 “Strong Buy” Healthcare Stocks to Buy Now

7 Healthcare Stocks Worth Your Time Now

More Articles

Volume:

Previous Close -

Market Cap 5.15B

PE Ratio -9.33

EPS -4.82

Volume (Avg. Vol.) 1.01M

Day's Range $44.64 - $45.54

52-Week Range $34.00 - $63.00

Dividend & Yield N/A (N/A)

NTRA Stock Predictions, Articles, and Natera Inc News

From InvestorPlace
From the Web

7 Exciting Biotech Stocks to Buy Now

By Louis Navellier, Editor, Growth Investor Dec 2, 2019

Many of these biotech companies are beating the Nasdaq Biotech Index. With cutting-edge therapies, these are great names to buy.

3 Stocks to Watch on Wednesday: Caleres Inc (CAL), Everi Holdings Inc (EVRI) and Natera Inc (NTRA)

By Karl Utermohlen, InvestorPlace Writer Mar 14, 2018

Caleres (CAL), Everi Holdings (EVRI) and Natera (NTRA) all reported on their quarterly earnings results after the bell. Here's what you should know.

Natera down 3%, prices $250M follow-on offering (NASDAQ:NTRA)

From Seeking Alpha Sep 7, 2023

Natera (NTRA) priced its underwritten public offering of 4.55M shares at a price to the public of $55.00 per share

Why Natera Stock Is Soaring Today

From The Motley Fool Aug 4, 2023

This DNA testing leader passed the test in Q2.

Natera wins favorable ruling in CareDx false advertising lawsuit (NASDAQ:NTRA)

From Seeking Alpha Jul 17, 2023

Genetic testing company Natera (NTRA) said on Monday that a Delaware court issued a decision in its favor in the false advertising lawsuit brought by rival CareDx (CDNA). The...

Acumen, BridgeBio, Arcus among BTIG's top healthcare picks for 2H 2023 (BBIO)

From Seeking Alpha Jul 9, 2023

Acumen (ABOS), Establishment Labs (ESTA), Arcus (RCUS) and BridgeBio (BBIO) are four of BTIG's top picks for small and mid-cap healthcare stocks for 2H 2023. Read more here.

SVB Securities Sticks to Its Buy Rating for Natera (NTRA)

From TipRanks Nov 14, 2022

In a report released on November 9, Puneet Souda from SVB Securities maintained a Buy rating on Natera (NTRA – Research Report), with a price target of $70.00...

Natera (NTRA) Gets a Buy from BTIG

From TipRanks Nov 4, 2022

BTIG analyst Mark Massaro reiterated a Buy rating on Natera (NTRA – Research Report) on November 2 and set a price target of $95.00. The company’s share...